On October 21, 2026 Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company"), a clinical-stage biotechnology company developing immunotherapies for cancer patients, reported that members of its executive team will participate in the following investor conferences:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Stifel Healthcare Conference

Dates: November 10–12, 2026
Location: New York, United States
Fireside chat:

Date: November 10, 2026
Time: 2:00 p.m. ET / 8:00 p.m. CET
To enter the live webcast, please click here
The link to access the live webcast of the presentation will be available on the Events page of the Investors section of Innate Pharma’s website. A replay of the presentation will be available following the event.

Jefferies Global Healthcare Conference

Dates: November 16-19, 2026
Location: London, United Kingdom

(Press release, Innate Pharma, OCT 21, 2026, View Source [SID1234673655])